NASDAQ:SANA

Sana Biotechnology Stock Insider Trading

Healthcare > Biotechnology

Buy SANA

*Your capital is at risk

$3.12

-0.120 (-3.70%)

At Close: Jun 03, 2026

Sana Biotechnology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 98.99. In total, the insiders bought 8.96M and sold 71.1K SANA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	98.99
● Buy	8.96M shares
● Sell	71.1K shares
84% Buy Activity Moderate Positive Correlation
Buy Signal High Confidence Mar 24, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 98.99. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (84% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 06, 2026 Buy	Common Stock A-Award	Bishop Hans Edgar Director	Director	7 763 Value: $25.0K
Mar 24, 2026 Buy	Restricted Stock Units	Patel Dhavalkumar Dhirajlal EVP, Chief Scientific Officer	Officer	112 500 Value: $328.5K
Mar 24, 2026 Buy	Stock Option (Right to Buy)	Patel Dhavalkumar Dhirajlal EVP, Chief Scientific Officer	Officer	506 250 Value: $1.73M
Mar 24, 2026 Buy	Stock Option (Right to Buy)	Patel Dhavalkumar Dhirajlal EVP, Chief Scientific Officer	Officer	375 000 Value: $956.3K
Mar 24, 2026 Buy	Common Stock	Patel Dhavalkumar Dhirajlal EVP, Chief Scientific Officer	Officer	0 Value: $0
Mar 24, 2026 Buy	Stock Option (Right to Buy)	Patel Dhavalkumar Dhirajlal EVP, Chief Scientific Officer	Officer	515 000 Value: $3.01M
Mar 09, 2026 Sell	Common Stock F-InKind	Wyrick Susan D. See Remarks	Officer	1 045 Value: $3K
Mar 09, 2026 Sell	Common Stock F-InKind	Wyrick Susan D. See Remarks	Officer	3 342 Value: $10.5K
Mar 09, 2026 Sell	Common Stock F-InKind	Harr Steve President & CEO	CEO / President	11 526 Value: $36.1K
Mar 09, 2026 Sell	Common Stock F-InKind	Harr Steve President & CEO	CEO / President	12 819 Value: $39.7K
Mar 07, 2026 Buy	Common Stock M-Exempt	Wyrick Susan D. See Remarks	Officer	3 250 Value: $10.1K
Mar 07, 2026 Buy	Common Stock M-Exempt	Harr Steve President & CEO	CEO / President	50 000 Value: $156.0K
Mar 07, 2026 Buy	Restricted Stock Units M-Exempt	Wyrick Susan D. See Remarks	Officer	3 250 Value: $10.1K
Mar 07, 2026 Buy	Restricted Stock Units M-Exempt	Harr Steve President & CEO	CEO / President	50 000 Value: $156.0K
Mar 06, 2026 Buy	Common Stock M-Exempt	Wyrick Susan D. See Remarks	Officer	10 416 Value: $32.8K
Mar 06, 2026 Buy	Restricted Stock Units M-Exempt	Harr Steve President & CEO	CEO / President	41 666 Value: $131.2K
Mar 06, 2026 Buy	Common Stock M-Exempt	Harr Steve President & CEO	CEO / President	41 666 Value: $131.2K
Mar 06, 2026 Buy	Restricted Stock Units M-Exempt	Wyrick Susan D. See Remarks	Officer	10 416 Value: $32.8K
Mar 05, 2026 Buy	Restricted Stock Units A-Award	Harr Steve President & CEO	CEO / President	200 000 Value: $682.0K
Mar 05, 2026 Buy	Stock Option (Right to Buy) A-Award	Harr Steve President & CEO	CEO / President	900 000 Value: $3.07M
Mar 05, 2026 Buy	Stock Option (Right to Buy) A-Award	Wyrick Susan D. See Remarks	Officer	206 250 Value: $703.3K
Mar 05, 2026 Buy	Restricted Stock Units A-Award	Wyrick Susan D. See Remarks	Officer	45 833 Value: $156.3K
Mar 03, 2026 Sell	Common Stock F-InKind	Wyrick Susan D. See Remarks	Officer	491 Value: $2K
Mar 02, 2026 Buy	Common Stock M-Exempt	Wyrick Susan D. See Remarks	Officer	1 525 Value: $6K
Mar 02, 2026 Buy	Restricted Stock Units M-Exempt	Wyrick Susan D. See Remarks	Officer	1 525 Value: $6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SANA BIOTECHNOLOGY, INC.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin ...

Read Full Profile Here